Synthetic lipopeptides: a novel class of anti-infectives

Bibliography

• ZASLOFF M: Antimicrobial peptides of multicellular organisms. Nature (2002) 415(6870):389-395.
   PubMed Web of Science ®Google Scholar
• PERRON GG, ZASLOFF M, BELL G: Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. (2006) 273(1583):251-256.
   PubMed Web of Science ®Google Scholar
• HORIANOPOULOU M, LAMBROPOULOS S, PAPAFRAGAS E, FALAGAS ME: Effect of aerosolized colistin on multidrug-resistant Pseudomonas aeruginosa in bronchial secretions of patients without cystic fibrosis. J. Chemother. (2005) 17(5):536-538.
   PubMed Web of Science ®Google Scholar
• FALAGAS ME, KASIAKOU SK: Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. (2005) 40(9):1333-1341.
   PubMed Web of Science ®Google Scholar
• LEDSON MJ, GALLAGHER MJ, COWPERTHWAITE C, CONVERY RP, WALSHAW MJ: Four years' experience of intravenous colomycin in an adult cystic fibrosis unit. Eur. Respir. J. (1998) 12(3):592-594.
   PubMed Web of Science ®Google Scholar
• MAJERLE A, KIDRIC J, JERALA R: Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain. J. Antimicrob. Chemother. (2003) 51(5):1159-1165.
   PubMed Web of Science ®Google Scholar
• EISENSTEIN BI: Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections. Expert Opin. Investig. Drugs (2004) 13(9):1159-1169.
   PubMed Web of Science ®Google Scholar
• ALDER JD: Daptomycin: a new drug class for the treatment of Gram-positive infections. Drugs Today (Barc.) (2005) 41(2):81-90.
   PubMed Web of Science ®Google Scholar
• LOHNER K, BLONDELLE SE: Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. Comb. Chem. High Throughput Screen. (2005) 8(3):241-256.
   PubMed Web of Science ®Google Scholar
• CHAN DI, PRENNER EJ, VOGEL HJ: Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta (2006) 1758(9):1184-1202.
   PubMed Web of Science ®Google Scholar
• STROM MB, HAUG BE, SKAR ML et al.: The pharmacophore of short cationic antibacterial peptides. J. Med. Chem. (2003) 46(9):1567-1570.
   PubMed Web of Science ®Google Scholar
• HAUG BE, STROM MB, SVENDSEN JS: The medicinal chemistry of short lactoferricin-based antibacterial peptides. Curr. Med. Chem. (2007) 14(1):1-18.
   PubMed Web of Science ®Google Scholar
• BUNKOCZI G, VERTESY L, SHELDRICK GM: Structure of the lipopeptide antibiotic tsushimycin. Acta Crystallogr. D Biol. Crystallogr. (2005) 61(Part 8):1160-1164.
   PubMed Web of Science ®Google Scholar
• FUJINO M: On glumamycin, a new antibiotic. VI. An approach to the amino acid sequence. Bull. Chem. Soc. Jpn. (1965) 38:517-522.
   PubMed Web of Science ®Google Scholar
• FUJINO M, INOUE M, UEYANAGI J, MIYAKE A: On glumamycin, a new antibiotic. V. The steric configuration of α, β-diaminobutyric acid. Bull. Chem. Soc. Jpn. (1965) 38:515-517.
   PubMed Web of Science ®Google Scholar
• REDIN GS, MC CM: Aspartocin. IV. Activity against experimental infections in mice. Antibiot. Ann. (1959) 7:213-219.
   PubMedGoogle Scholar
• KIRSCH EJ, DORNBUSH AC, BACKUS EJ: Aspartocin. III. In vitro antimicrobial properties. Antibiot. Ann. (1959) 7:205-212.
   PubMedGoogle Scholar
• HAUSMANN WK, STRUCK AH, MARTIN JH, BARRITT RH, BOHONOS N: Structure determination of fatty acids from the antibiotic aspartocin. Antimicrob. Agents Chemother. (Bethesda) (1963) 161:352-359.
   PubMedGoogle Scholar
• BALTZ RH, MIAO V, WRIGLEY SK: Natural products to drugs: daptomycin and related lipopeptide antibiotics. Nat. Prod. Rep. (2005) 22(6):717-741.
   PubMed Web of Science ®Google Scholar
• BORDERS DB, LEESE RA, JAROLMEN H et al.: Laspartomycin, an acidic lipopeptide antibiotic with a unique peptide core. J. Nat. Prod. (2007) 70:443-446.
   PubMed Web of Science ®Google Scholar
• NAKANO MM, ZUBER P: Molecular biology of antibiotic production in Bacillus. Crit. Rev. Biotechnol. (1990) 10(3):223-240.
   PubMed Web of Science ®Google Scholar
• KIM K, JUNG SY, LEE DK et al.: Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2. Biochem. Pharmacol. (1998) 55(7):975-985.
   PubMed Web of Science ®Google Scholar
• HEERKLOTZ H, SEELIG J: Leakage and lysis of lipid membranes induced by the lipopeptide surfactin. Eur. Biophys. J. (2007) 36(4-5):305-314.
   PubMed Web of Science ®Google Scholar
• LOMAKINA NN, BRAZHNIKOVA MG: Chemical composition of crystallomycin. Biokhimiia (1959) 24(3):425-431.
   PubMedGoogle Scholar
• CHAPMAN TM, GOLDEN MR: Polymyxin B. NMR evidence for a peptide antibiotic with folded structure in water. Biochem. Biophys. Res. Commun. (1972) 46(6):2040-2047.
   PubMed Web of Science ®Google Scholar
• ZIDOVETZKI R, BANERJEE U, HARRINGTON DW, CHAN SI: NMR study of the interactions of polymyxin B, gramicidin S, and valinomycin with dimyristoyllecithin bilayers. Biochemistry (1988) 27(15):5686-5692.
   PubMed Web of Science ®Google Scholar
• PRISTOVSEK P, KIDRIC J: Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study. J. Med. Chem. (1999) 42(22):4604-4613.
   PubMed Web of Science ®Google Scholar
• KATO T, SHOJI T: The structure of octapeptin D (studies on antibiotics from the genus Bacillus. XXVIII). J. Antibiot. (Tokyo) (1980) 33(2):186-191.
   PubMed Web of Science ®Google Scholar
• TONIOLO C, PEGGION C, CRISMA M et al.: Structure determination of racemic trichogin A IV using centrosymmetric crystals. Nat. Struct. Biol. (1994) 1(12):908-914.
   PubMedGoogle Scholar
• MAZZUCA C, STELLA L, VENANZI M et al.: Mechanism of membrane activity of the antibiotic trichogin GA IV: a two-state transition controlled by peptide concentration. Biophys. J. (2005) 88(5):3411-3421.
   PubMed Web of Science ®Google Scholar
• GATTO E, MAZZUCA C, STELLA L et al.: Effect of peptide lipidation on membrane perturbing activity: a comparative study on two trichogin analogues. J. Phys. Chem. B. Condens. Matter Mater. Surf. Interfaces Biophys. (2006) 110(45):22813-22818.
   PubMed Web of Science ®Google Scholar
• YIN N, MARSHALL RL, MATHESON S, SAVAGE PB: Synthesis of lipid A derivatives and their interactions with polymyxin B and polymyxin B nonapeptide. J. Am. Chem. Soc. (2003) 125(9):2426-2435.
   PubMed Web of Science ®Google Scholar
• WARREN HS, KANIA SA, SIBER GR: Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide. Antimicrob. Agents Chemother. (1985) 28(1):107-112.
   PubMed Web of Science ®Google Scholar
• TSUBERY H, OFEK I, COHEN S, FRIDKIN M: Structure–function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria. J. Med. Chem. (2000) 43(16):3085-3092.
   PubMed Web of Science ®Google Scholar
• TSUBERY H, OFEK I, COHEN S, FRIDKIN M: N-terminal modifications of polymyxin B nonapeptide and their effect on antibacterial activity. Peptides (2001) 22(10):1675-1681.
   PubMed Web of Science ®Google Scholar
• BRANDENBURG K, DAVID A, HOWE J et al.: Temperature dependence of the binding of endotoxins to the polycationic peptides polymyxin B and its nonapeptide. Biophys. J. (2005) 88(3):1845-1858.
   PubMed Web of Science ®Google Scholar
• FALAGAS ME, KASIAKOU SK: Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis. Infection (2007) 35(1):3-10.
   PubMed Web of Science ®Google Scholar
• FRIEDRICH CL, MOYLES D, BEVERIDGE TJ, HANCOCK RE: Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. (2000) 44(8):2086-2092.
   PubMed Web of Science ®Google Scholar
• PATRZYKAT A, FRIEDRICH CL, ZHANG L, MENDOZA V, HANCOCK RE: Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother. (2002) 46(3):605-614.
   PubMed Web of Science ®Google Scholar
• JUNG D, ROZEK A, OKON M, HANCOCK RE: Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chem. Biol. (2004) 11(7):949-957.
   PubMed Web of Science ®Google Scholar
• STRAUS SK, HANCOCK RE: Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta (2006) 1758(9):1215-1223.
   PubMed Web of Science ®Google Scholar
• LOHNER K: Development of Novel Antimicrobial Agents: Emerging Strategies. Lohner K (Ed.), Horizon Scientific Press, Wymondham, Norfolk, UK (2001).
   Google Scholar
• PESCHEL A: How do bacteria resist human antimicrobial peptides? Trends Microbiol. (2002) 10(4):179-186.
   PubMed Web of Science ®Google Scholar
• MOSKOWITZ SM, ERNST RK, MILLER SI: PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. (2004) 186(2):575-579.
   PubMed Web of Science ®Google Scholar
• TZENG YL, AMBROSE KD, ZUGHAIER S et al.: Cationic antimicrobial peptide resistance in Neisseria meningitidis. J. Bacteriol. (2005) 187(15):5387-5396.
   PubMed Web of Science ®Google Scholar
• KRAUS D, PESCHEL A: Molecular mechanisms of bacterial resistance to antimicrobial peptides. Curr. Top. Microbiol. Immunol. (2006) 306:231-250.
   PubMed Web of Science ®Google Scholar
• RAJA NS, SINGH NN: Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital. J. Microbiol. Immunol. Infect. (2007) 40(1):45-49.
   PubMedGoogle Scholar
• LITTLEWOOD JM, KOCH C, LAMBERT PA et al.: A ten year review of colomycin. Respir. Med. (2000) 94(7):632-640.
   PubMed Web of Science ®Google Scholar
• MARTY FM, YEH WW, WENNERSTEN CB et al.: Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J. Clin. Microbiol. (2006) 44(2):595-597.
   PubMed Web of Science ®Google Scholar
• MANCEK M, PRISTOVSEK P, JERALA R: Identification of LPS-binding peptide fragment of MD-2, a toll-receptor accessory protein. Biochem. Biophys. Res. Commun. (2002) 292(4):880-885.
   PubMed Web of Science ®Google Scholar
• ANDRA J, LOHNER K, BLONDELLE SE et al.: Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide. Biochem. J. (2005) 385(Part 1):135-143.
   PubMed Web of Science ®Google Scholar
• ANDRA J, GUTSMANN T, GARIDEL P, BRANDENBURG K: Mechanisms of endotoxin neutralization by synthetic cationic compounds. J. Endotoxin Res. (2006) 12(5):261-277.
   PubMedGoogle Scholar
• JERALA R, PORRO M: Endotoxin neutralizing peptides. Curr. Top. Med. Chem. (2004) 4(11):1173-1184.
   PubMed Web of Science ®Google Scholar
• SHALEV DE, ROTEM S, FISH A, MOR A: Consequences of N-acylation on structure and membrane binding properties of dermaseptin derivative K4-S4-(1-13). J. Biol. Chem. (2006) 281(14):9432-9438.
   PubMed Web of Science ®Google Scholar
• THOMAS CJ, SUROLIA N, SUROLIA A: Surface plasmon resonance studies resolve the enigmatic endotoxin neutralizing activity of polymyxin B. J. Biol. Chem. (1999) 274(42):29624-29627.
   PubMed Web of Science ®Google Scholar
• THOMAS CJ, SUROLIA A: Kinetics of the interaction of endotoxin with polymyxin B and its analogs: a surface plasmon resonance analysis. FEBS Lett. (1999) 445(2-3):420-424.
   PubMed Web of Science ®Google Scholar
• THENNARASU S, LEE DK, TAN A, PRASAD KARI U, RAMAMOORTHY A: Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843. Biochim. Biophys. Acta (2005) 1711(1):49-58.
   PubMed Web of Science ®Google Scholar
• ZWEYTICK D, PABST G, ABUJA PM et al.: Influence of N-acylation of a peptide derived from human lactoferricin on membrane selectivity. Biochim. Biophys. Acta (2006) 1758(9):1426-1435.
   PubMed Web of Science ®Google Scholar
• DE VISSER PC, KRIEK NM, VAN HOOFT PA et al.: Solid-phase synthesis of polymyxin B1 and analogues via a safety-catch approach. J. Pept. Res. (2003) 61(6):298-306.
   PubMedGoogle Scholar
• MALINA A, SHAI Y: Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide. Biochem. J. (2005) 390(Part 3):695-702.
   PubMed Web of Science ®Google Scholar
• BRAHMACHARY M, KRISHNAN SP, KOH JL et al.: ANTIMIC: a database of antimicrobial sequences. Nucleic Acids Res. (2004) 32(Database Issue):D586-D589.
   PubMed Web of Science ®Google Scholar
• YANG D, BIRAGYN A, HOOVER DM, LUBKOWSKI J, OPPENHEIM JJ: Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Ann. Rev. Immunol. (2004) 22:181-215.
   PubMed Web of Science ®Google Scholar
• BOWDISH DM, DAVIDSON DJ, HANCOCK RE: Immunomodulatory properties of defensins and cathelicidins. Curr. Top. Microbiol. Immunol. (2006) 306:27-66.
   PubMed Web of Science ®Google Scholar
• MAJERLE A, KIDRIC J, JERALA R: Production of stable isotope enriched antimicrobial peptides in Escherichia coli: an application to the production of a 15N-enriched fragment of lactoferrin. J. Biomol. NMR (2000) 18(2):145-151.
   PubMed Web of Science ®Google Scholar
• BRUCKDORFER T, MARDER O, ALBERICIO F: From production of peptides in milligram amounts for research to multi-tons quantities for drugs of the future. Curr. Pharm. Biotechnol. (2004) 5(1):29-43.
   PubMed Web of Science ®Google Scholar
• NGUYEN KT, RITZ D, GU JQ et al.: Combinatorial biosynthesis of novel antibiotics related to daptomycin. Proc. Natl. Acad. Sci. USA (2006) 103(46):17462-17467.
   PubMed Web of Science ®Google Scholar
• TSUBERY H, OFEK I, COHEN S, EISENSTEIN M, FRIDKIN M: Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization. Mol. Pharmacol. (2002) 62(5):1036-1042.
   PubMed Web of Science ®Google Scholar
• LEADBETTER MR, ADAMS SM, BAZZINI B et al.: Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424). J. Antibiot. (Tokyo) (2004) 57(5):326-336.
   PubMed Web of Science ®Google Scholar
• LAOHAVALEESON S, KUTI JL, NICOLAU DP: Telavancin: a novel lipoglycopeptide for serious gram-positive infections. Expert Opin. Investig. Drugs (2007) 16(3):347-357.
   PubMed Web of Science ®Google Scholar
• PACE JL, YANG G: Glycopeptides: update on an old successful antibiotic class. Biochem. Pharmacol. (2006) 71(7):968-980.
   PubMed Web of Science ®Google Scholar
• HIGGINS DL, CHANG R, DEBABOV DV et al.: Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. (2005) 49(3):1127-1134.
   PubMed Web of Science ®Google Scholar
• VAN BAMBEKE F: Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy. Curr. Opin. Investig. Drugs (2006) 7(8):740-749.
   PubMed Web of Science ®Google Scholar
• ARNOLD RR, COLE MF, MCGHEE JR: A bactericidal effect for human lactoferrin. Science (1977) 197(4300):263-265.
   PubMed Web of Science ®Google Scholar
• WAKABAYASHI H, MATSUMOTO H, HASHIMOTO K et al.: N-acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity. Antimicrob. Agents Chemother. (1999) 43(5):1267-1269.
   PubMed Web of Science ®Google Scholar
• AVRAHAMI D, SHAI Y: Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action. Biochemistry (2003) 42(50):14946-14956.
   PubMed Web of Science ®Google Scholar
• AVRAHAMI D, SHAI Y: A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. J. Biol. Chem. (2004) 279(13):12277-12285.
   PubMed Web of Science ®Google Scholar
• AVRAHAMI D, SHAI Y: Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity. Biochemistry (2002) 41(7):2254-2263.
   PubMed Web of Science ®Google Scholar
• MOR A, NGUYEN VH, DELFOUR A, MIGLIORE-SAMOUR D, NICOLAS P: Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin. Biochemistry (1991) 30(36):8824-8830.
   PubMed Web of Science ®Google Scholar
• MOR A, NICOLAS P: The NH2-terminal α-helical domain 1–18 of dermaseptin is responsible for antimicrobial activity. J. Biol. Chem. (1994) 269(3):1934-1939.
   PubMed Web of Science ®Google Scholar
• PORAT Y, MARYNKA K, TAM A, STEINBERG D, MOR A: Acyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microflora. Antimicrob. Agents Chemother. (2006) 50(12):4153-4160.
   PubMed Web of Science ®Google Scholar
• ROTEM S, RADZISHEVSKY I, MOR A: Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives. Antimicrob. Agents Chemother. (2006) 50(8):2666-2672.
   PubMed Web of Science ®Google Scholar
• RADZISHEVSKY IS, ROTEM S, ZAKNOON F et al.: Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. Antimicrob. Agents Chemother. (2005) 49(6):2412-2420.
   PubMed Web of Science ®Google Scholar
• DAGAN A, EFRON L, GAIDUKOV L, MOR A, GINSBURG H: In vitro antiplasmodium effects of dermaseptin S4 derivatives. Antimicrob. Agents Chemother. (2002) 46(4):1059-1066.
   PubMed Web of Science ®Google Scholar
• MAKOVITZKI A, AVRAHAMI D, SHAI Y: Ultrashort antibacterial and antifungal lipopeptides. Proc. Natl. Acad. Sci. USA (2006) 103(43):15997-16002.
   PubMed Web of Science ®Google Scholar
• ZORKO M, MAJERLE A, SARLAH D et al.: Combination of antimicrobial and endotoxin-neutralizing activities of novel oleoylamines. Antimicrob. Agents Chemother. (2005) 49(6):2307-2313.
   PubMed Web of Science ®Google Scholar
• LI CH, BUDGE LP, DRISCOLL CD et al.: Incremental conversion of outer-membrane permeabilizers into potent antibiotics for Gram-negative bacteria. J. Am. Chem. Soc. (1999) 121(5):931-940.
   Web of Science ®Google Scholar
• SAVAGE PB, LI C, TAOTAFA U, DING B, GUAN Q: Antibacterial properties of cationic steroid antibiotics. FEMS Microbiol. Lett. (2002) 217(1):1-7.
   PubMed Web of Science ®Google Scholar
• BALAKRISHNA R, WOOD SJ, NGUYEN TB et al.: Structural correlates of antibacterial and membrane-permeabilizing activities in acylpolyamines. Antimicrob. Agents Chemother. (2006) 50(3):852-861.
   PubMed Web of Science ®Google Scholar
• MILLER KA, SURESH KUMAR EV, WOOD SJ et al.: Lipopolysaccharide sequestrants: structural correlates of activity and toxicity in novel acylhomospermines. J. Med. Chem. (2005) 48(7):2589-2599.
   PubMed Web of Science ®Google Scholar
• LOCKWOOD NA, HASEMAN JR, TIRRELL MV, MAYO KH: Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains. Biochem. J. (2004) 378(Part 1):93-103.
   PubMed Web of Science ®Google Scholar
• TSAN P, VOLPON L, BESSON F, LANCELIN JM: Structure and dynamics of surfactin studied by NMR in micellar media. J. Am. Chem. Soc. (2007) 129(7):1968-1977.
   PubMed Web of Science ®Google Scholar
• JAPELJ B, ZORKO M, MAJERLE A et al.: The acyl group as the central element of the structural organization of antimicrobial lipopeptide. J. Am. Chem. Soc. (2007) 129(5):1022-1023.
   PubMed Web of Science ®Google Scholar
• BALL LJ, GOULT CM, DONARSKI JA, MICKLEFIELD J, RAMESH V: NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin. Org. Biomol. Chem. (2004) 2(13):1872-1878.
   PubMed Web of Science ®Google Scholar
• CREAGH EM, O'NEILL LA: TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. (2006) 27(8):352-357.
   PubMed Web of Science ®Google Scholar
• BEUTLER B, HOEBE K, DU X, ULEVITCH RJ: How we detect microbes and respond to them: the Toll-like receptors and their transducers. J. Leukoc. Biol. (2003) 74(4):479-485.
   PubMed Web of Science ®Google Scholar
• AKIRA S, UEMATSU S, TAKEUCHI O: Pathogen recognition and innate immunity. Cell (2006) 124(4):783-801.
   PubMed Web of Science ®Google Scholar
• JERALA R: Structural biology of the LPS recognition. Int. J. Med. Microbiol. (2007) (In Press).
   PubMedGoogle Scholar
• TAKEDA K, TAKEUCHI O, AKIRA S: Recognition of lipopeptides by Toll-like receptors. J. Endotoxin Res. (2002) 8(6):459-463.
   PubMedGoogle Scholar
• BLANDER JM, MEDZHITOV R: Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature (2006) 440(7085):808-812.
   PubMed Web of Science ®Google Scholar
• HOLZHEIMER RG: Antibiotic induced endotoxin release and clinical sepsis: a review. J. Chemother. (2001) 13(Spec. No. 1)(1):159-172.
   PubMed Web of Science ®Google Scholar
• COHEN J: The immunopathogenesis of sepsis. Nature (2002) 420(6917):885-891.
   PubMed Web of Science ®Google Scholar
• ULEVITCH RJ: Molecular mechanisms of innate immunity. Immunol. Res. (2000) 21(2-3):49-54.
   PubMed Web of Science ®Google Scholar
• AVRAHAMI D, OREN Z, SHAI Y: Effect of multiple aliphatic amino acids substitutions on the structure, function, and mode of action of diastereomeric membrane active peptides. Biochemistry (2001) 40(42):12591-12603.
   PubMed Web of Science ®Google Scholar
• OREN Z, RAMESH J, AVRAHAMI D et al.: Structures and mode of membrane interaction of a short α-helical lytic peptide and its diastereomer determined by NMR, FTIR, and fluorescence spectroscopy. Eur. J. Biochem. (2002) 269(16):3869-3880.
   PubMedGoogle Scholar
• FEDER R, DAGAN A, MOR A: Structure–activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. J. Biol. Chem. (2000) 275(6):4230-4238.
   PubMed Web of Science ®Google Scholar
• GAIDUKOV L, FISH A, MOR A: Analysis of membrane-binding properties of dermaseptin analogues: relationships between binding and cytotoxicity. Biochemistry (2003) 42(44):12866-12874.
   PubMed Web of Science ®Google Scholar
• RYDLO T, ROTEM S, MOR A: Antibacterial properties of dermaseptin S4 derivatives under extreme incubation conditions. Antimicrob. Agents Chemother. (2006) 50(2):490-497.
   PubMed Web of Science ®Google Scholar
• RADZISHEVSKY I, KRUGLIAK M, GINSBURG H, MOR A: Antiplasmodial activity of lauryl-lysine oligomers. Antimicrob. Agents Chemother. (2007)51(5):1753-1759.
   Google Scholar
• MARYNKA K, ROTEM S, PORTNAYA I, COGAN U, MOR A: In vitro discriminative antipseudomonal properties resulting from acyl substitution of N-terminal sequence of dermaseptin s4 derivatives. Chem. Biol. (2007) 14(1):75-85.
   PubMed Web of Science ®Google Scholar
• JAPELJ B, PRISTOVSEK P, MAJERLE A, JERALA R: Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide. J. Biol. Chem. (2005) 280(17):16955-16961.
   PubMed Web of Science ®Google Scholar